Abstract
AbstractIn patients with advanced cancer, the achievement of a peaceful death through palliative care is highly desired. The preservation of quality of life (QOL) is a primary goal of palliative treatments; measures of QOL thus serve as important indicators of the treatment efficacy. Patient ratings have traditionally been viewed as the gold standard for QOL measures because the physical and emotional symptoms that influence QOL are subjective phenomena. However, the palliative patient group may experience difficulties with symptom self-report. This raises serious issues in clinical trials concerning non-response bias and generalizability of the data. To address the non-response issue, proxy informants are often elicited to act as surrogate respondents for patients with advanced disease. However, satisfactory levels of agreement between patient and proxy QOL appraisals must be demonstrated before caregivers (i.e., family members and close friends) can be deemed reliable sources of QOL assessments. This re...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.